Lipid lowering may reduce major cardiovascular events, regardless of pre-treatment cholesterol levels

Affiliations

Comment

Malcolm Law et al. Evid Based Cardiovasc Med. 2006 Mar.

. 2006 Mar;10(1):8-10.

doi: 10.1016/j.ebcm.2006.01.003.

¹ Barts and The London Queen Mary's School of Medicine and Dentistry, University of London, UK.

No abstract available

Comment on

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Baigent C, et al. Lancet. 2005 Oct 8;366(9493):1267-78. doi: 10.1016/S0140-6736(05)67394-1. Epub 2005 Sep 27. Lancet. 2005. PMID: 16214597